Godrej Consumer Products
Godrej Consumer Products makes household insecticides (HIT, Good Knight), soaps (Cinthol), and hair/personal care products, with large operations in India, Indonesia, and Africa.
- Stock at 52-week low
- Down 44% from Sep-2024 peak
- Margin fell despite 19% revenue growth
- CEO resigned Aug 2026
- Dividend record date Nov 4
Updated on 1 Nov 2026 · Data as of 30 Oct 2026
Get this report as a PDF free, straight to your inbox.
Snapshot
- Share price
- ₹818.00
- 30 Oct 2026
- 52-week range
- ₹818.00 – ₹1,235.57
- All-time peak
- ₹1,460.97
- 12 Sept 2024 · −44.0% from peak
- Dividend yield
- 2.44%
- Price history since
- 2002
- About 24 years of prices
What's happening
An interim dividend of ₹5/share has a record date of November 4, 2026 - just three days away. This follows Q2 FY27 results (quarter to Sept 2026, reported Oct 29) where revenue rose 19% YoY to about ₹4,413 crore and profit rose 14% to ₹523 crore, but the stock fell further anyway because EBITDA margin contracted to 18.58% from 19.77% a year earlier on palm-oil and crude-linked input cost inflation. This comes months after CEO Sudhir Sitapati resigned on August 11, 2026 - just three days after shareholders had approved a fresh five-year term for him - triggering a one-day 10% stock fall; Aasif Malbari was named the new MD & CEO the next day.
In plain terms
This is the company behind everyday products like HIT mosquito sprays and Cinthol soap, sold in India and increasingly in Indonesia and Africa. Sales are growing at a healthy double-digit pace, but the company is keeping less of each rupee of sales as profit because the raw materials it needs (palm oil, crude-derived chemicals) have become more expensive. On top of that, its CEO abruptly quit right after being reappointed, which has unsettled investors. The stock has nearly halved from its 2024 peak, and that decline looks like a genuine business and governance worry, not a statistical trick from a stock split or demerger.
Quarters
Q2 FY27 (Jul-Sep 2026): revenue ₹4,413 crore (+19% YoY), net profit ₹523 crore (+14% YoY), but EBITDA margin fell ~119 basis points to 18.58% from 19.77% - management called input cost inflation 'one of the highest in many years.' Q1 FY27 revenue was ₹4,225 crore (+18.3% YoY); Q3 FY26 revenue was ₹4,079 crore (+8.8% YoY) with a stronger margin of 21.6%, confirming the latest quarter's margin dip is a real deterioration, not noise. By segment, home care/insecticides grew 19% in value with market-share gains, while soaps were described as 'stable despite price hikes and grammage reduction' - meaning some of that stability came from charging more or giving less product per pack (shrinkflation), not pure volume growth, so treat the soaps number as partly price/pack-size driven rather than a clean read on demand. Internationally, Indonesia revenue rose 20% (helped by heavier mosquito-season demand) and the Africa/Middle East/US (GAUM) business rose 40% in rupee terms (23% in constant currency) for a seventh straight quarter of double-digit growth, which management called structural rather than one-off. Full-year FY27 guidance of high-single-digit India volume growth and double-digit consolidated revenue/EBITDA growth was reaffirmed.
Performance
Heads-up on splits: Godrej Consumer Products has split its shares or issued bonus shares before (most recently ×1.5 on 12 Sept 2018, 2-for-1 on 22 Jun 2017 and 4-for-1 on 24 Aug 2006). A sudden price drop around a split date is usually just the price adjusting for the extra shares, not a crash.
Share price
−25.1% over 1 year
Returns by period
| Period | Godrej Consumer Products | Nifty 50 | DABUR |
|---|---|---|---|
| 3 months | −23.2% | −5.5% | −13.3% |
| 1 year | −25.1% | −10.9% | −25.8% |
| 3 years | −13.2% | +20.8% | −27.9% |
| 5 years | −11.6% | +28.6% | −34.9% |
₹100 invested on 1 Nov 2021 became…
- Godrej Consumer Products₹88
- Nifty 50₹129
- DABUR₹65
The stock closed at ₹818 on Oct 30, 2026, exactly at its 52-week low, and 44% below its September 2024 peak of ₹1,460.97. There is no recent split or demerger distorting this figure - the company's last corporate actions were stock splits in 2006, 2017, and 2018, all well before the period in question - so this is a genuine, uncushioned price decline. Over 1 year the stock is down 25.1% versus the Nifty's -10.9% and peer Dabur's -25.8% (so this is partly a sector-wide FMCG derating, not unique to Godrej). More troubling is the longer horizon: over 3 years the stock is down 13.2% in absolute terms while the Nifty gained 20.8%, and over 5 years it is down 11.6% versus a 28.6% Nifty gain. A stock that has delivered negative absolute returns over five years while the broader market nearly doubled is a weak long-term outcome that deserves to be stated plainly, not buried under short-term dividend or margin commentary.
Dividend
Paid in the last 12 months
₹20.00 per share
Dividend yield
2.44%
Dividend yield is the last 12 months of dividends divided by today's share price. A 2.4% yield means every ₹100 of Godrej Consumer Products shares paid about ₹2.4 in dividends over the past year. Past payouts can change.
Recent dividends
| Date | Per share |
|---|---|
| 13 Aug 2026 | ₹5.00 |
| 12 May 2026 | ₹5.00 |
| 30 Jan 2026 | ₹5.00 |
| 7 Nov 2025 | ₹5.00 |
| 13 Aug 2025 | ₹5.00 |
| 13 May 2025 | ₹5.00 |
| 3 Feb 2025 | ₹5.00 |
| 31 Oct 2024 | ₹5.00 |
Valuation
Valuation multiples vary meaningfully by data source: P/E ranges from about 39x (Screener) to roughly 45x and even 55x on other aggregators, and P/B from about 6.6x to an outlier near 10.6x. The 39.4x P/E and 6.6x P/B cluster together and look more reliable; the higher figures appear to use stale or differently-defined trailing earnings and are set aside as outliers rather than averaged in. Why the stock has gotten cheaper is clear - a near-halving in price plus a margin-compressing cost environment and a leadership shock. Whether it is actually cheap is a separate question: even after the fall, a P/E in the high-30s to mid-40s is still a rich multiple in absolute terms for a company whose margins just contracted, so the price drop so far reflects reduced growth/margin confidence rather than the stock having become a bargain.
Growth
Revenue growth is real and reasonably broad-based - domestic home care gained share, and international units (Indonesia, GAUM) grew strongly - so this is not a business standing still. But it is not cleanly volume-led: soaps 'stability' was achieved partly through price hikes and reduced pack sizes (grammage cuts), and the overall EBITDA margin fell even as revenue grew, meaning costs are rising faster than the company can pass through or absorb. That combination - rising sales, falling margin - is the classic sign of a business fighting input-cost inflation rather than one compounding profitably on volume alone.
Health
Balance-sheet risk looks low: debt-to-equity is roughly 0.4 and ROCE sits around 19-20%, so the company is not over-leveraged. The real concern here is business risk, not financial risk - specifically, margin pressure from palm-oil and crude-linked input costs that management says is among the worst in years, plus a CEO who quit abruptly. Whether reported profit is converting cleanly into operating cash flow was not independently verified in this review - check the cash flow statement on Screener before treating the ₹523 crore quarterly profit as equivalent to cash generated.
Ownership
Promoters (the Godrej family group) held 53.05% as of the September 2026 quarter, essentially unchanged over the past year, and no new pledging was found in recent filings. A September 24, 2026 block deal of about 1.02 crore shares (~₹892 crore) was an intra-promoter-group transfer, not a sale to the open market, so total promoter ownership was unaffected. Institutional ownership is rotating: foreign institutional (FII) holding has fallen steadily from 15.4% to 11.0% over the last four quarters, while domestic institutional (DII) holding has risen from 16.5% to 20.7% over the same period - foreign investors have been net sellers even as domestic funds absorb the supply. No internationally prominent individual investor was identified on the shareholder register in this review.
The View
The one thing to watch
The next quarterly EBITDA margin print (Q3 FY27, likely around late January 2027) will show whether palm-oil/input cost pressure is easing or persisting, and will be the first full quarter under new CEO Aasif Malbari's strategic direction.
Strengths
- +Revenue grew 19% YoY to ~₹4,413 crore in Q2 FY27, with home care/insecticides up 19% in value alongside market-share gains
- +GAUM (Africa/Middle East/US) revenue rose 40% in rupee terms for a seventh consecutive quarter of double-digit growth, which management calls structural
- +Low financial leverage with debt-to-equity near 0.4 and ROCE around 19-20%, limiting balance-sheet risk
- +Indonesia business grew 20%, benefiting from stronger mosquito-season demand for insecticides
Watchpoints
- !EBITDA margin contracted to 18.58% from 19.77% a year earlier on palm-oil and crude-linked cost inflation that management called among the worst in years
- !CEO Sudhir Sitapati resigned on Aug 11, 2026, just three days after a fresh five-year term was approved; new CEO Aasif Malbari took over Aug 12, adding leadership transition risk
- !Stock is at its 52-week low, down 44% from its Sept-2024 peak, and has delivered negative absolute returns over both 3 and 5 years while the Nifty gained 21% and 29% respectively over the same periods
- !Soap segment's reported 'stability' is partly a product of price hikes and grammage (pack-size) reduction rather than pure volume demand - underlying soap volumes are weaker than the topline suggests
How sure are we about the data? · Moderate
Q2 FY27 revenue, profit, and margin figures were corroborated across multiple sources. Valuation multiples diverged significantly: P/E ranged 39.4x-54.7x and P/B 6.6x-10.6x across sources; the lower, Screener-sourced figures were treated as the reliable cluster and the higher ones set aside as likely stale or inconsistently defined. Promoter holding of 53.05% (from exchange-filed shareholding data) was used over a conflicting 63.21% figure found on one site, which appears outdated or incorrect. Operating cash flow conversion from reported profit was not independently verified - check this on Screener before relying on it.
Keep it for later
Get the Godrej Consumer Products report as a PDF
The full report, neatly laid out with charts and tables, sent to your inbox. Handy to read offline or share.
Reports are refreshed every quarter, about three days after each company announces its results.
Ticker Tales is not a SEBI-registered investment adviser or research analyst. This report is for learning only and is not investment advice. Data as of 30 Oct 2026.